- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
BETMIGA - 50mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G04BD12 | B | Mirabegron - 50mg | 7733 | 27414/1 | BETMIGA | 50mg | 30 | Tablet, prolonged release | Oral | Mersaco | Astellas Pharma Europe BV | The Netherlands | 3,758,727 L.L | 23.08 | B | Astellas Pharma Europe BV | The Netherlands | 2/5/2024 | 0 |